Enhanced intestinal adenomatous polyp formation in Pms2-/-;: Min mice

被引:0
作者
Baker, SM
Harris, AC
Tsao, JL
Flath, TJ
Bronner, CE
Gordon, M
Shibata, D
Liskay, RM
机构
[1] Oregon Hlth Sci Univ, Dept Med & Mol Genet, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Dept Pathol, Portland, OR 97201 USA
[3] Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA
[4] Univ So Calif, Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Analysis of two human familial cancer syndromes, hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis, indicates that mutations in either one of four DNA mismatch repair gene homologues or the adenomatous polyposis coli (APC) gene, respectively, are important for the development of colorectal cancer, To further investigate the role of DNA mismatch repair in intestinal tumorigenesis, we generated mice with mutations in both Ape and the DNA mismatch repair gene, Pms2. Whereas Pms2-deficient mice do not develop intestinal tumors, mice deficient in Pms2 and heterozygous for Min, an allele of Apc, develop approximately three times the number of small intestinal adenomas and four times the number of colon adenomas relative to Alin and Pms2(+/-); Min mice, Although Pms2 deficiency clearly increases adenoma formation in the Min background, histological analysis indicated no clear evidence for progression to carcinoma.
引用
收藏
页码:1087 / 1089
页数:3
相关论文
共 50 条
  • [31] Dietary retinoic acid supplementation stimulates intestinal tumour formation and growth in multiple intestinal neoplasia (Min)/+ mice
    Mollersen, L
    Paulsen, JE
    Olstorn, HB
    Knutsen, HK
    Alexander, J
    CARCINOGENESIS, 2004, 25 (01) : 149 - 153
  • [32] Haplotype insufficiency for SOCS2 enhances intestinal growth and promotes polyp formation in GH-transgenic mice
    Michaylira, Carmen Z.
    Ramocki, Nicole
    Simmons, James G.
    McNaughton, Kirk K.
    Woosley, John T.
    Greenhalgh, Christopher J.
    Rigby, Rachael
    Lund, P. Kay
    GASTROENTEROLOGY, 2006, 130 (04) : A337 - A337
  • [33] Chemopreventative activity of hydrokysymatairesinol in adenomatous polyposis colimultiple intestinal neoplasia (Apc)Min mice (vol 159, pg 183, 2000)
    Oikannen, SI
    Pajari, AM
    Mutanen, M
    CANCER LETTERS, 2000, 161 (02) : 251 - +
  • [34] Intestinal tumorigenesis in Min mice is enhanced by X-irradiation in an age-dependent manner
    Okamoto, M
    Yonekawa, H
    JOURNAL OF RADIATION RESEARCH, 2005, 46 (01) : 83 - 91
  • [35] A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in ApcMin/+ mice
    Ni, Y.
    Wong, V. H. Y.
    Tai, W. C. S.
    Li, J.
    Wong, W. Y.
    Lee, M. M. L.
    Fong, F. L. Y.
    El-Nezami, H.
    Panagiotou, G.
    JOURNAL OF APPLIED MICROBIOLOGY, 2017, 122 (03) : 770 - 784
  • [36] Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc Min/+ mutation (vol 17, 1, 2016)
    Dorman, Alexandra
    Baer, Daria
    Tomlinson, Ian
    Mott, Richard
    Iraqi, Fuad A.
    BMC GENETICS, 2016, 17
  • [37] Resistant carbohydrates stimulate cell proliferation and crypt fission in wild-type mice and in the Apc Min+ mouse model of intestinal cancer, association with enhanced polyp development
    Mandir, Nikki
    Englyst, Hans
    Goodlad, Robert A.
    BRITISH JOURNAL OF NUTRITION, 2008, 100 (04) : 711 - 721
  • [38] Nabumetone inhibition of intestinal tumorigenesis in MIN mice: Modulation of Bcl-2.
    Roy, HK
    Lu, K
    GASTROENTEROLOGY, 1997, 112 (04) : A647 - A647
  • [39] Antitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in ApcΔ716 mice involves stromal COX-2
    Fujishita, Teruaki
    Kajino-Sakamoto, Rie
    Kojima, Yasushi
    Taketo, Makoto Mark
    Aoki, Masahiro
    CANCER SCIENCE, 2015, 106 (06) : 692 - 699
  • [40] The plant lignans matairesinol and secoisolariciresinol administered to Min mice do not protect against intestinal tumor formation
    Pajari, AM
    Smeds, AI
    Oikarinen, SI
    Eklund, PC
    Sjöholm, RE
    Mutanen, M
    CANCER LETTERS, 2006, 233 (02) : 309 - 314